Tibra Equities Europe’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-22,600	Closed	-$604K	–	212
2019 Q2	$604K	Buy	+22,600	New	+$604K	0.04%	180
2018 Q4	–	Sell	-12,354	Closed	-$256K	–	181
2018 Q3	$256K	Buy	+12,354	New	+$256K	0.03%	186